Literature DB >> 28840580

FMT in IBD: What Have We Learned?

Colleen R Kelly1, Jessica R Allegretti2.   

Abstract

Mesh：

Year:  2017        PMID： 28840580     DOI： 10.1007/s10620-017-4713-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  17 in total

Review 1.  Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Authors:  Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun
Journal:  Am J Gastroenterol       Date:  2013-02-26       Impact factor: 10.864

2.  Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.

Authors:  Krista M Newman; Kevin M Rank; Byron P Vaughn; Alexander Khoruts
Journal:  Gut Microbes       Date:  2017-01-19

3.  European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.

Authors:  M J T Crobach; T Planche; C Eckert; F Barbut; E M Terveer; O M Dekkers; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2016-07-25       Impact factor: 8.067

4.  Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Monika Fischer; Dina Kao; Colleen Kelly; Aishwarya Kuchipudi; Syed-Mohammed Jafri; Mark Blumenkehl; Douglas Rex; Mark Mellow; Nirmal Kaur; Harry Sokol; Gwen Cook; Matthew J Hamilton; Emmalee Phelps; Brian Sipe; Huiping Xu; Jessica R Allegretti
Journal:  Inflamm Bowel Dis       Date:  2016-10       Impact factor: 5.325

5.  Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection.

Authors:  Clayton M Spiceland; Sahil Khanna; Darrell S Pardi
Journal:  J Clin Gastroenterol       Date:  2018-02       Impact factor: 3.062

6.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

Review 7.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

8.  Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.

Authors:  Henry A Horton; Seper Dezfoli; Dror Berel; Julianna Hirsch; Andrew Ippoliti; Dermot McGovern; Manreet Kaur; David Shih; Marla Dubinsky; Stephan R Targan; Phillip Fleshner; Eric A Vasiliauskas; Jonathan Grein; Rekha Murthy; Gil Y Melmed
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

9.  Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Authors:  Suchitra K Hourigan; Sankar R Chirumamilla; Tracy Ross; Jonathan E Golub; Shervin Rabizadeh; Shehzad A Saeed; Charles O Elson; Ciaran P Kelly; Karen C Carroll; Maria Oliva-Hemker; Cynthia Sears
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

10.  Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.

Authors:  Sahil Khanna; Yoshiki Vazquez-Baeza; Antonio González; Sophie Weiss; Bradley Schmidt; David A Muñiz-Pedrogo; John F Rainey; Patricia Kammer; Heidi Nelson; Michael Sadowsky; Alexander Khoruts; Stefan L Farrugia; Rob Knight; Darrell S Pardi; Purna C Kashyap
Journal:  Microbiome       Date:  2017-05-15       Impact factor: 14.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.